ClinicalTrials.gg
RecruitingNCT06980675Updated May 20, 2025

Ozonized Olive Oil in the Treatment of Periodontal Pockets

An interventional study of Activated Ozonized Olive Oil Gel and Placebo gel in Periodontal Pocket, sponsored by University of Bari. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-20.

Sponsored by University of Bari · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Oct 2021, registered May 2024).
  • Started Oct 2021; still recruiting 5 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A randomized controlled clinical trial was conducted on 16 patients (8 males and 8 women) who were diagnosed chronic periodontitis. All the patients has been divided by randomization in two groups: control group treated with placebo gel and experimental group treated with gel based on ozonated EVO olive oil.

Both group after the evaluation of inclusion and exclusion criteria during the first visit, were subjected to hygiene treatment of removal tartar deposit, considered as standard of therapy for periodontitis.

After 15 days the hygiene treatment, patients were been randomized in two groups following the flow chart (t0) starting with: periodontal probing, microbiological samples and the first administration of gel. Next week (t1), has been collected the compliance and did the second administration of gel; the procedures will be the same also for another week (t2), until the last week (t3) when has been registered the second periodontal probing and did the second microbiological samples.

Data were collected to software Microsoft Excel and all the data analysis were conducted on this software to highlight significant differences between both groups. As the primary outcome was continuous variable and assuming normal distribution bilateral parametric test T-student was performed. An alpha error of 5% was considered, Beta error was not calculated as this was a pilot study.

02

Conditions studied

  • Periodontal Pocket

Keywords

  • Ozonated Olive Oil
  • Periodontal Pocket
  • Periodontal Disease
03

In context

Periodontal Pocket

130 studies on the registry are indexed under Periodontal Pocket; 35 are open to participants now.

This study's planned enrollment of 20 is below the median of 30 across 113 interventional studies indexed under Periodontal Pocket.

Browse Periodontal Pocket studies →

Lead sponsor

University of Bari is the lead sponsor of 76 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with stage II, III, or IV periodontitis according to the new 2017 World Workshop periodontal classification
  • Patients of either sex and older than 18 years of age
  • Probing Pocket Depth (PPD) greater than or equal to 4 mm at 3 sites
  • Patients who have signed consent to the study
  • Collaborating patients

Exclusion criteria

Exclusion Criteria:

  • age \< 18 years and/or inability to provide written ;
  • absence of family or social welfare support;
  • non-drug-induced gingival hypertrophy,
  • severe smokers (more than 20 cigarettes per day),
  • consumers of high levels of alcohol,
  • patients on treatment,
  • diabetic patient,
  • immunodepressive therapies,
  • chemotherapies,
  • radiotherapies,
  • pregnancy states;
  • lack of collaboration for ongoing postoperative reevaluations.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Ozonized Olive Oil Intervention Group

    It has been administrated in the form of gel once a week for three weeks

    Device: Activated Ozonized Olive Oil Gel

  • Placebo comparator
    Placebo Controlled Group

    Same description of Interventional Group

    Other: Placebo gel

Interventions

  • DeviceActivated Ozonized Olive Oil Gel

    It is a natural oil which has been ozonized to improve the antimicrobial activity against periodontopathogenic bacterias

  • OtherPlacebo gel

    Placebo gel with same texture, color, way of administration and taste of Activated Ozonized Olive Oil Gel

06

What researchers measure

Primary outcomes

  1. Difference of Probing Pocket Depth (PPD)

    It is a measures in mm assessed with periodontal probe in periodontal pockets

    Time frame: One measure to assess inclusion, second mesure at randomization and third measure after 21 days

Secondary outcomes

  1. Difference of Total microbial load

    Expressed in percentage, samples performed with sterile paper cone and measurement performed with Applied Biosystem 7500 sequence detection system with Real Time PCR

    Time frame: One measure at randomization and second measure after 21 days

07

Study locations

1 of 1 sites recruiting
  • Odontostomatologic Departement of Policlinic of Bari
    Bari, BA 70124, Italy
    Recruiting
    • Massimo Petruzzi, PhD, MD · Contactmassimo.petruzzi@uniba.it · 3335763120
    • Fabio Vittorio Ciccone, MD · Sub investigator
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06980675
Lead sponsor
University of Bari
Responsible party
Massimo Petruzzi (Clinical Professor of Odontostomatology, University of Bari) — Principal investigator
First posted
May 20, 2025
Start date
Oct 25, 2021
Primary completion
Nov 1, 2024
Completion
May 2025 (estimated)
Last update
May 20, 2025

Study contacts

Fabio Vittorio Ciccone, MD
Contact
fabio.ciccone5@gmail.com
3887589165 ext. +39
Massimo Petruzzi, PhD, MD
Contact
massimo.petruzzi@uniba.it
3335763120 ext. +39
Massimo Petruzzi, PhD, MD
principal investigator · University of Bari

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion